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Abstract
Background: While it is widely held that non-surgical management should be the first line of approach
in patients with lumbar spinal stenosis (LSS), little is known about the efficacy of non-surgical treatments
for this condition. Data are needed to determine the most efficacious and safe non-surgical treatment
options for patients with LSS. The purpose of this paper is to describe the clinical outcomes of a novel
approach to patients with LSS that focuses on distraction manipulation (DM) and neural mobilization (NM).
Methods: This is a prospective consecutive case series with long term follow up (FU) of fifty-seven
consecutive patients who were diagnosed with LSS. Two were excluded because of absence of baseline
data or failure to remain in treatment to FU. Disability was measured using the Roland Morris Disability
Questionnaire (RM) and pain intensity was measured using the Three Level Numerical Rating Scale (NRS).
Patients were also asked to rate their perceived percentage improvement.
Results: The mean patient-rated percentage improvement from baseline to the end to treatment was
65.1%. The mean improvement in disability from baseline to the end of treatment was 5.1 points. This was
considered to be clinically meaningful. Clinically meaningful improvement in disability from baseline to the
end of treatment was seen in 66.7% of patients. The mean improvement in "on average" pain intensity was
1.6 points. This did not reach the threshold for clinical meaningfulness. The mean improvement in "at
worst" pain was 3.1 points. This was considered to be clinically meaningful.
The mean duration of FU was 16.5 months. The mean patient-rated percentage improvement from
baseline to long term FU was 75.6%. The mean improvement in disability was 5.2 points. This was
considered to be clinically meaningful. Clinically meaningful improvement in disability was seen in 73.2% of
patients. The mean improvement in "on average" pain intensity from baseline to long term FU was 3.0
points. This was considered to be clinically meaningful. The mean improvement in "at worst" pain was 4.2
points. This was considered to be clinically meaningful. Only two patients went on to require surgery.
No major complications to treatment were noted.
Conclusion: A treatment approach focusing on DM and NM may be useful in bringing about clinically
meaningful improvement in disability in patients with LSS.
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Lumbar spinal stenosis (LSS) is a common and often dis-
abling disorder that generally occurs in the sixth or sev-
enth decade of life [1], although it can uncommonly occur
in younger individuals [2]. The incidence of this condi-
tion has been reported to be 8–11% [3], with a slight pre-
ponderance in women [1]. LSS can lead to low back and
leg pain, most typically via encroachment on the central
canal, lateral recess, or lateral canal. The source of the
encroachment is typically vertebral body osteophytes,
hypertrophy of the ligamentum flavum or zygapophyseal
joint, or a combination of these [1]. The posterior longi-
tudinal ligament may be involved in some individuals [4].
The development of these degenerative changes is often
accompanied by restriction of segmental mobility [1].
One of the hallmarks of LSS is neurogenic claudication, in
which the patient develops low back and/or leg pain after
a period of walking that progressively worsens as walking
is continued, with improvement or resolution when walk-
ing ceases and the patient sits or flexes the lumbar spine
[5].
LSS is one of the most common reasons for spine surgery
in older people [6], although little is known about the effi-
cacy of surgical management of patients with LSS, partic-
ularly compared to non-surgical management [7]. It is
generally felt that most patients with LSS should be man-
aged non-surgically before considering surgical interven-
tion [8], but little is also known about what non-surgical
approaches are most efficacious.
LSS can involve the central canal, the lateral recess, the lat-
eral canal, or any combination of these [6]. This can lead
to nerve root pain and dysfunction, i.e., radiculopathy.
The pathophysiology of radiculopathy secondary to LSS is
different from that of radiculopathy secondary to herni-
ated disc (HD). In recent years it has increasingly become
clear that much of the pain with acute radiculopathy sec-
ondary to HD is chemical, not compressive in nature
[9,10]. The chemical inflammatory process with HD is ini-
tiated by the presence of nuclear material. But with LSS, it
is likely that a different, or additional, mechanism that is
involved in the production of nerve root pain.
Experimental evidence has suggested that chronic com-
pression of the nerve root in LSS causes compromise of
blood flow leading to congestion, ischemia, and intraneu-
ral edema [11]. This then leads to the development of per-
iradicular fibrosis [12]. Increased pain with walking that is
relieved with lumbar flexion (neurogenic claudication) is
one of the hallmarks for LSS. Neurogenic claudication
likely arises from increased metabolic demands of the
nerve root in the presence of vascular compromise [13]
and traction on the adhesed nerve root when lower
extremity movement occurs during walking [14]. This
may explain why the SLR is often negative in pts with LSS
[8], but is typically positive in patients with herniated
disc. With LSS, compression, vascular compromise and
perineural fibrosis dominate the pathophysiological pic-
ture, thus maneuvers that increase IVF pressure, i.e., exten-
sion [15], or increase metabolic demands of the nerve
root and movement of the fibrotic nerve root, as with
walking, exacerbate the pain.
A non-surgical approach that attempts to target the
unique pathophysiology of LSS may be best able to rap-
idly improve pain and function in these patients. Such a
treatment strategy would attempt to mobilize the seg-
ment(s) involved, decompress the involved nerve root(s)
and mobilize the involved nerve root(s) to break up per-
iradicular adhesion, thus releasing nerve root entrapment,
and restoring vascular function. It would appear that
maintaining intersegmental and nerve root mobility
would then be important in order to maximize the long
term benefit of treatment.
The purpose of this study was to assess, using rigorous
outcome measures, the results of a non-surgical manage-
ment strategy for patients with LSS that focuses on distrac-
tion manipulation (DM) and neural mobilization (NM).
Theoretically, these methods were employed in order to
improve motion segment mobility (DM) and nerve root
mobility (NM). It is not known whether these modalities
actually create these effects, and this study does not evalu-
ate these theoretical mechanisms. But the outcome of a
strategy that focused on these methods was assessed. This
strategy has not previously been evaluated.
Methods
Data were gathered on all consecutive patients meeting
the inclusion criteria who were seen from 5/17/00 to 9/
19/03. Inclusion criteria were:
1. Leg Pain with or without low back pain
2. MRI or CT documented lateral canal, lateral recess or
central canal stenosis, alone or in combination, in the
lumbar spine or clear neurogenic claudication as deter-
mined by history, i.e., a description by the patient of the
onset of leg pain with walking that steadily increased with
continued walking, and resolved or improved with rest
with the spine in flexion.
3. All patients must remain in treatment for at least one re-
exam (typically performed every 3–4 weeks) and com-
plete the prescribed course of treatment.
4. Ability to speak EnglishPage 2 of 8
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2006, 7:16 http://www.biomedcentral.com/1471-2474/7/16Exclusion criteria were:
1. Radiculopathy by other causes such as herniated disc
2. Claudication symptoms determined to be vascular
3. Systemic illness
4. Contraindications to the study treatments
5. Unable to communicate well in English
6. Worker's Compensation/Personal Injury cases
Outcome Measures
• Disability was measured using the Roland Morris Low
Back Pain and Disability Questionnaire (RM) [16].
• Pain intensity was measured using the Three Level
Numerical Rating Scale (NRS) [17]. With this, each
patient was given an form on which three scales were sup-
plied ranging from 0 (no pain) to 10 (unbearable pain).
These scales allowed the patient rated pain intensity at the
moment, on average, and at its worst.
• Patients were asked to rate their perceived percentage
improvement. That is, patients were provided with a
numerical scale ranging from 0% (no improvement) to
100% (complete resolution) and were asked to circle the
numerical value that best represented their level of
improvement, if any.
Outcome measurements were performed at baseline and
again at each scheduled re-examination visit, usually every
3–4 weeks until the end of treatment. As this was a prag-
The application of distraction manipulationFigure 1
The application of distraction manipulation.Page 3 of 8
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with the usual protocol utilized at the Rhode Island Spine
Center, no set number of treatments, or set duration of
treatment, was assigned. Rather, patients were treated in
the manner in which the treating chiropractors in the
study (DRM and AAG) would normally utilize in every
day practice.
FU measures were then obtained by a research assistant by
phone or mail for long term FU.
Other data gathered included age, sex, date of last visit,
duration of symptoms, primary diagnosis, secondary
diagnosis (if any), rheumatologic or orthopedic condi-
tions affecting the spine, number of visits, levels affected
based on MRI or CT, history of lumbar surgery and type,
treatments applied in the clinic, concomitant treatments
outside the clinic, and complications to the study treat-
ments.
Interventions
Patients were treated according to the usual protocol uti-
lized at the Rhode Island Spine Center for patients with
radiculopathy secondary to LSS. The primary interven-
tions, which were utilized in all patients, were:
- Distraction manipulation (DM) – This is a manipulative
technique developed by Cox [18]. Although other forms
of manipulation are believed to be effective in patients
with LSS [19], no form other than DM was used with the
patients in this study.
In applying DM, the patient lay prone on a table that
allows for distraction of the spine through inferiorward
and flexion movement of the lower body (figure 1). This
maneuver has been demonstrated to decrease intradiscal
pressure [20] and is believed to create vertebral motions
and increase the intervertebral foramen [21].
- Neural mobilization (NM) – This a manual and exercise
oriented method that is theorized to mobilize nerve roots
that are suspected to be the source of nerve root pain
[22,23]. Distal mobilization was applied by having the
patient lie supine while the doctor or therapist dorsiflexed
the ankle and flexed the hip with the knee extended. The
leg was raised until the practitioner felt the "barrier" [24],
i.e., the point at which tension is initially felt. The foot is
then moved alternately into plantar flexion and dorsiflex-
ion repeatedly for several cycles.
- Exercises that are taught to the patient and which are
designed to compliment the DM and NM by mobilizing
the lumbar spine and the involved nerve root(s). These
included the "cat and camel" exercise [25] in which the
patient is quadruped and alternately flexes and extends
(within the comfort level) the cervical and lumbar spine,
and "nerve flossing" exercises [25], which attempt to
mobilize the involved nerve roots and there associated
peripheral nerves.
DM and NM and the related exercises are the constants of
treatment in this study – all patients are treated with these
methods. In addition, certain patients may also have been
had other modalities included in their individual pro-
grams, such as mobilization exercises and spinal stabiliza-
tion exercise [26,27]. While the frequency and duration of
care were determined on an individual basis, patients
were generally seen 2–3 times per week for 3 weeks ini-
tially, after which the first follow up (FU) reexamination
was performed, which included the primary outcome
measures (see below). This was typically followed by
either continued frequency of 2 times per week or a reduc-
tion in frequency to 1 time per week, though some
patients who are fully recovered were released after the
first FU reexamination to 3 week FU.
This was a practice-based project in which the data gath-
ered were those data that are collected as part of the rou-
tine of practice at the Rhode Island Spine Center. Also, the
treatments provided each patient were those that are pro-
vided in the routine care of patients with LSS at the Rhode
Island Spine Center. No experimental procedures were
used and no personally identifiable information on any
patient is presented. The study protocol was reviewed and
Table 1: Baseline characteristics.
Variable N Mean Median Standard Deviation Range
Age 55 65.2 67.0 9.6 32.0–80.0
Male 19 - - - -
Female 36 - - - -
Duration (weeks) 55 134.2 26.0 299.3 1.0–1560
RM score baseline 51 10.6 11.0 4.5 2.0–20.0
Current Pain baseline 54 3.9 3.3 2.9 0–9.0
Average Pain baseline 53 5.2 5.0 2.6 0–10.0
Worst Pain baseline 54 8.7 9.0 2.0 5.0–10.0
Legend: RM – Roland Morris Low Back Pain and Disability questionnaire; FU – follow upPage 4 of 8
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2006, 7:16 http://www.biomedcentral.com/1471-2474/7/16approved by the HIPAA compliance officer of the Rhode
Island Spine Center. Because of this, it was not deemed
necessary to obtain formal approval from an Institutional
Review Board.
Statistical analysis
Descriptive statistics, including frequencies and propor-
tions for categorical variables, and means, standard devia-
tions, and ranges for continuous variables, were
computed. Improvements in current, average, and worst
pain (NRS) and disability (RM) from baseline to the last
follow-up re-examination and to the long-term assess-
ment were measured by computing change scores for each
case and taking the group mean, as well as by computing
percent change in each outcome variable ([baseline score
– follow-up score]/baseline score). 95% confidence inter-
vals around the change scores were computed; paired t-
tests were used to assess the statistical significance of the
change scores. A three point or greater improvement on
the RM was deemed clinically meaningful [28-30]. Data
were stratified by sex in an a priori subgroup analysis.
Results
Table 1 presents the sociodemographic and baseline clin-
ical characteristics of the patients.
Data were gathered prospectively on 57 consecutive
patients, 36 female and 19 male. Two patients were
excluded for lack of baseline data or failure to remain in
treatment until the first FU reexamination. The mean age
was 65.2 years. The mean duration of symptoms prior to
starting treatment was 134.2 weeks. Three patients had a
history of previous lumbar spine surgery. For the 43
patients in whom imaging was available, lateral canal or
lateral recess stenosis was present in 33 patients and cen-
tral canal stenosis was present in 28 patients. The majority
of patients had both lateral and central stenosis. The most
common level of involvement was L4-5 (34 patients). The
next most common level of involvement was L3-4 (20
patients) followed by L5-S1 (16 patients), L2-3 (seven
patients) and L1-2 (one patient). One patient had
involvement at all lumbar levels. The majority of patients
had involvement at more than one level. In the remaining
patients, LSS was established by the presence of low back
pain and leg pain in an older individual with a clear his-
tory of neurogenic claudication.
All patients were treated with DM, as close to the at the
level(s) of LSS as possible, and neural mobilization,
attempting to target the nerve root(s) involved. Twenty-
nine patients were taking some form of oral medication
(non-steroidal anti-inflammatory drugs, muscle relaxants,
analgesics) at intake. No attempt was made to alter medi-
cation usage and continued medication usage after intake
was not recorded, thus it is impossible to know how long
each patient continued on his or her medication. Two
patients were referred for epidural steroid injections.
The mean total number of treatments was 13.3 (range 2–
50). This included visits to both the chiropractic physician
and physical therapist. Forty-four patients were reached
for long term FU. The mean duration of FU was 16.5
months (range 3–48 months).
The main results are presented in Table 2.
Statistically significant and clinically meaningful changes
were observed in the mean patient-rated percentage
improvements from baseline to the end to treatment
(95% CI 55.9–74.2; P < 0.0001) and from baseline to
long term FU (95% CI 21.1–61.9; P = 0.0002). The mean
improvement in disability as measured by the RM score
from baseline to the end of treatment was 5.1 points (95%
CI 3.4–6.8; P < 0.0001) and from baseline to long term FU
was 5.2 points (95% CI 3.0–7.3; P < 0.0001), each exceed-
ing the three points that has been estimated to be the
threshold for clinically meaningful improvement using
the RM [28-30]. The mean percentage improvements in
Table 2: Outcomes from baseline to last re-exam and to long-term follow-up.
Variable Last FU Long Term FU
N Mean Median 95% CI P value N Mean Median 95% CI P value
Change in RM Sore 48 5.1 4.0 3.4 – 6.8 <0.0001 41 5.2 5.0 3.0 – 7.3 <0.0001
Change in Current Pain 49 1.8 2.0 0.9 – 2.7 0.0002 45 2.1 2.0 1.0 – 3.1 0.0003
Change in Average Pain 47 1.6 1.0 0.6 – 2.7 0.0024 44 3.0 3.0 2.0 – 4.1 <0.0001
Change in Worst Pain 47 3.1 2.0 2.0 – 4.3 <0.0001 45 4.2 6.0 2.8 – 5.5 <0.0001
Self Rated Improvement 52 65.1 80.0 55.9 – 74.2 <0.0001 44 75.6 90.0 65.8 – 85.4 <0.0001
% Change in RM Score 48 42.0 56.1 24.5 – 59.6 <0.0001 41 41.5 53.8 21.1 – 61.9 0.0002
% Change in Current Pain 45 48.8 83.3 25.7 – 72.0 0.0001 40 38.4 100.0 0.1 – 76.8 0.0497
% Change in Average Pain 43 27.2 33.3 6.7 – 47.8 0.0106 41 51.7 75.0 33.5 – 69.9 <0.0001
% Change in Worst Pain 47 34.8 20.0 22.3 – 47.3 <0.0001 45 44.7 57.9 28.7 – 60.7 <0.0001
Legend: RM – Roland Morris Low Back Pain and Disability questionnaire; FU – follow up; CI – confidence interval for meanPage 5 of 8
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24.5–59.6; P < 0.0001) and from baseline to long term FU
(95% CI 21.1–61.9; P = 0.0002) were also statistically and
clinically significant. Of the 48 patients in whom data
were available regarding improvement in disability as
measured by the RM, clinically meaningful improvement
(i.e., 3+ points [28-30]) was seen in 32 patients (66.7%).
For long term FU, among the 41 patients for whom these
data were available, clinically meaningful improvement
in disability was observed in 30 (73.2%).
Mean and mean percentage improvements in pain inten-
sity "currently", "on average" and "at its worst" from base-
line to end of treatment and from baseline to long term
FU were all statistically significant. All were also clinically
meaningful (i.e. 2 points or greater[31]) with the excep-
tion of pain intensity "currently" from baseline to the end
of treatment and "on average" from baseline to the end of
treatment (table 2). Only two patients went on to require
surgery.
No major complications to treatment were seen in any
patient. Transient increased pain was seen in 12 patients,
nine after treatment with DM and NM (in one, this
occurred on two occasions), two after home exercise for
NM and one in which a patient had increased leg pain
after falling asleep on an ice pack. In all cases, the
increased pain was minor and transient.
Discussion
The results of this study suggest that the combination of
DM and NM may be useful for patients with LSS. Interpre-
tation of the results must be made with caution, however,
as the absence of randomization and control does not
eliminate the possibility of treatment bias and does not
allow one to distinguish these outcomes from those that
would result from natural history. However, in a natural
history study by Johnsson [32], 70% of patients were
found to be unchanged over 49 months, and 15%
improved. So it would appear from this that, while deteri-
oration is not the norm in patients with SS, most patients
would not be expected to improve over time.
Nonetheless, clinically meaningful improvement in disa-
bility was seen in over two-thirds of the patients, and the
improvement appeared to be maintained over an average
of 16.5 months after cessation of treatment. The sustained
improvement over the long term may relate to the empha-
sis in the management strategy on treatments that are
designed to specifically address the known pathophysiol-
ogy of LSS and on exercise that was designed to compli-
ment the DM and NM, with continuous monitoring of
compliance with home exercise throughout the treatment
process. However, this study's design does not allow for
firm conclusions to be drawn regarding this. Only two
patients went on to require surgery, suggesting that the
treatment approach studied here may be an effective alter-
native to surgery for patients with LSS.
This study can be examined in the light of other studies
that have looked at the effectiveness of non-surgical man-
agement of LSS, some of which have compared it to sur-
gery. In the Maine Lumbar Spine Study [33], Atlas, et al
compared non-surgical management, which was not
strictly defined, with surgery in 141 patients with LSS.
They found that at one year FU, the non-surgically treated
group had only improved by an average of 1.6 points on
the RM, compared to the surgical group, which improved
by an average of 8.4 points. At four years, the non-surgical
group improved an average of 3.5 points on the RM, while
the surgical group had improved by an average of 8.5
points [34]. This is contrasted with the 5.2 point improve-
ment seen in the present study as a result of the non-sur-
gical approach taken here. Simotas, et al [35] followed 49
patients treated with a non-surgical approach that
included oral non-steroidal or steroidal medication and
epidural steroid injection along with postural instruction
and mobilization and stabilization exercises. While RM
data was collected at baseline, no FU data on the RM are
provided. As such, it is difficult to directly compared the
Simotas, et al study with the present one. However, they
found that nine out of 49 patients (18.5%) required sur-
gery, compared to two out of 44 patients (4.5%) in the
present study.
From this, it is reasonable to conclude that the treatment
approach in this study is a viable alternative to surgery for
patients with LSS, and compares favorably with other
non-surgical approaches that have been studied. As the
efficacy of surgery does not appear to decrease if it is
delayed in favor of a non-surgical trial [36], most patients
with LSS should be treated non-surgically for a period of
time before considering operation. DM and NM may be
one non-surgical option that can be offered to patients.
The management strategy in this study focused on two
treatment modalities, DM and NM. DM may have bene-
fits that relate to biomechanical effects on the stenotic seg-
ment, such as reduction of intradiscal pressure [20] or
widening of the space in the region of the nerve root [21].
DM may also have neurophysiological effects that may be
helpful in patients with LSS, such as facilitation of afferent
input from mechanoreceptors [37], possibly helping to
improve proprioception, which has been shown to be
impaired in patients with LSS [38], or hypoalgesia [39].
While most of the studies on the neurophysiological
effects of spinal manipulation do not specifically assess
DM, evidence suggests that DM has similar neurophysio-
logical effects as other forms of manipulation [40].Page 6 of 8
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structures proximate to the neural elements that are being
compromised, as well as the neural elements themselves
[22]. This may help patients with LSS by releasing
perineural adhesions, thus decreasing traction strain on
the nerve root, especially with walking. A great deal more
basic science research into the effects of both DM and NM
is needed to investigate these proposed mechanisms.
No major complications were seen in any patient, and
transient, mild increase in symptoms was seen in 12
patients (21.8%). This is actually less than the 34–55%
rate of transient pain related to manipulative treatment in
general that has been reported in the literature [41,42].
However, rare complications may not be detected in a
sample size such as this one, so larger samples will be
required to further investigate the safety of this approach
to patients with LSS.
These patients were treated an average of 13.3 times. This
study does not allow one to draw conclusions about the
optimum number of treatments for patients with LSS.
However, it can reasonably be said that the 13.3 treat-
ments likely reflects an adequate number of treatments.
This may help the treating clinician in decision making
regarding how long to continue to treat a patient with LSS
using this approach. It would appear that a decrease of
three points on the RM instrument is a good indicator of
clinically meaningful improvement in patients with LSS
[28-30]. Thus, if, after 13 or so treatments, a minimum
improvement of three points on the RM questionnaire is
not seen, further treatment with DM and NM is not war-
ranted. It must be noted that a relatively wide range of
treatment visits (2–50) was seen in this study, suggesting
that individual differences in patient responses to treat-
ment exists which necessitates greater or fewer than the
mean number of treatments Nonetheless, 49 of 54
patients (91%) required between seven and 18 visits. So,
from the data presented here, it can be concluded that the
number of treatments required should be within six visits
of the mean in the majority of patients.
This study is useful in that it assesses the outcome of a
treatment approach in a "real world" environment. That
is, the patients in this practice-based study were treated as
they would be under normal circumstances according to
the protocol for patients with LSS utilized at the Rhode
Island Spine Center. There was no attempt to control the
number of visits or the types of treatments that were pro-
vided in addition to DM and NM. As such, however, there
is no way to tell the extent to which any particular treat-
ment contributed to the outcome in each case. Also, inter-
pretation of the results with regard to efficacy is not
possible because of the absence of randomization and
appropriate control group(s). The data presented here do
suggest, however that the combination of DM and NM
may be a useful approach for patients with LSS, and that
further investigation in the form of randomized, control-
led trials is warranted.
Limitations of this study include, as was stated earlier,
absence of randomization and appropriate control
groups. But this study was designed as an observational
study to undertake preliminary investigation of the use of
DM and NM in the management of patients with LSS.
Proper randomized, controlled trials are feasible in this
area. Also, twelve patients from this series did not have
imaging confirmation of the presence of LSS and the diag-
nosis was made based on the presence of low back pain
and/or leg pain in an older person with a clear history
consistent with neurogenic claudication. It is felt that
including these patients in the study is appropriate in that
neurogenic claudication is so characteristic of LSS [5], that
it is very unlikely that any other condition would be caus-
ing the pain in these patients. Finally, the average pain
intensity from baseline to the end of treatment was only
1.6 points. A change in 2 points on the NRS is generally
considered to be the threshold for clinically meaningful
improvement [31]. However, in spite of this, a clinically
meaningful change in disability was seen from baseline to
the end of treatment. Also, there was a mean 3 point
change in average pain intensity from baseline to final FU.
This change can be considered to be clinically meaningful.
Conclusion
The combination of DM and NM may be a safe and effec-
tive approach for patients with LSS. Because the sample
size is relatively small and there is no control group, firm
conclusions regarding this cannot be drawn. The outcome
of this approach compares favorably with other non-sur-
gical treatments, and treatment with DM and NM may be
a viable non-surgical option before considering surgery
for LSS. This approach deserves closer scrutiny in the form
of randomized controlled trials.
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